396 related articles for article (PubMed ID: 26872765)
21. Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening.
Howard DH; Richards TB; Bach PB; Kegler MC; Berg CJ
Cancer; 2015 Dec; 121(24):4341-7. PubMed ID: 26372542
[TBL] [Abstract][Full Text] [Related]
22. Lung cancer screening recommended for heavy smokers.
Cancer Discov; 2014 Mar; 4(3):OF8. PubMed ID: 24596223
[TBL] [Abstract][Full Text] [Related]
23. Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.
Katki HA; Kovalchik SA; Berg CD; Cheung LC; Chaturvedi AK
JAMA; 2016 Jun; 315(21):2300-11. PubMed ID: 27179989
[TBL] [Abstract][Full Text] [Related]
24. Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohort.
Ferketich AK; Niland JC; Mamet R; Zornosa C; D'Amico TA; Ettinger DS; Kalemkerian GP; Pisters KM; Reid ME; Otterson GA
Cancer; 2013 Feb; 119(4):847-53. PubMed ID: 23023590
[TBL] [Abstract][Full Text] [Related]
25. Identifying high-risk individuals for lung cancer screening: Going beyond NLST criteria.
Fu M; Travier N; Martín-Sánchez JC; Martínez-Sánchez JM; Vidal C; Garcia M;
PLoS One; 2018; 13(4):e0195441. PubMed ID: 29621354
[TBL] [Abstract][Full Text] [Related]
26. The performance of NLST screening criteria in Asian lung cancer patients.
Kumar V; Becker K; Zheng HX; Huang Y; Xu Y
BMC Cancer; 2015 Nov; 15():916. PubMed ID: 26582178
[TBL] [Abstract][Full Text] [Related]
27. Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients.
Zhou W; Heist RS; Liu G; Park S; Neuberg DS; Asomaning K; Wain JC; Lynch TJ; Christiani DC
Lung Cancer; 2006 Sep; 53(3):375-80. PubMed ID: 16814423
[TBL] [Abstract][Full Text] [Related]
28. Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status.
Baser S; Shannon VR; Eapen GA; Jimenez CA; Onn A; Lin E; Morice RC
Chest; 2006 Dec; 130(6):1784-90. PubMed ID: 17166997
[TBL] [Abstract][Full Text] [Related]
29. Prediction of Lung Cancer Screening Eligibility Using Simplified Criteria.
Triplette M; Donovan LM; Crothers K; Madtes DK; Au DH
Ann Am Thorac Soc; 2019 Oct; 16(10):1280-1285. PubMed ID: 31298946
[No Abstract] [Full Text] [Related]
30. Lung Cancer Risk and Demographic Characteristics of Current 20-29 Pack-year Smokers: Implications for Screening.
Pinsky PF; Kramer BS
J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26483244
[TBL] [Abstract][Full Text] [Related]
31. Incorporating both genetic and tobacco smoking data to identify high-risk smokers for lung cancer screening.
Jia G; Wen W; Massion PP; Shu XO; Zheng W
Carcinogenesis; 2021 Jun; 42(6):874-879. PubMed ID: 33640962
[TBL] [Abstract][Full Text] [Related]
32. Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial.
Rojewski AM; Tanner NT; Dai L; Ravenel JG; Gebregziabher M; Silvestri GA; Toll BA
Chest; 2018 Jul; 154(1):110-118. PubMed ID: 29793736
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult Smokers.
Aldrich MC; Mercaldo SF; Sandler KL; Blot WJ; Grogan EL; Blume JD
JAMA Oncol; 2019 Sep; 5(9):1318-1324. PubMed ID: 31246249
[TBL] [Abstract][Full Text] [Related]
34. Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data.
Williams RM; Li T; Luta G; Wang MQ; Adams-Campbell L; Meza R; Tammemägi MC; Taylor KL
Cancer; 2022 May; 128(9):1812-1819. PubMed ID: 35201610
[TBL] [Abstract][Full Text] [Related]
35. Screening for Lung Cancer - 10 States, 2017.
Richards TB; Soman A; Thomas CC; VanFrank B; Henley SJ; Gallaway MS; Richardson LC
MMWR Morb Mortal Wkly Rep; 2020 Feb; 69(8):201-206. PubMed ID: 32106215
[TBL] [Abstract][Full Text] [Related]
36. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
Ten Haaf K; Jeon J; Tammemägi MC; Han SS; Kong CY; Plevritis SK; Feuer EJ; de Koning HJ; Steyerberg EW; Meza R
PLoS Med; 2017 Apr; 14(4):e1002277. PubMed ID: 28376113
[TBL] [Abstract][Full Text] [Related]
37. Primary Care Provider and Patient Perspectives on Lung Cancer Screening. A Qualitative Study.
Kanodra NM; Pope C; Halbert CH; Silvestri GA; Rice LJ; Tanner NT
Ann Am Thorac Soc; 2016 Nov; 13(11):1977-1982. PubMed ID: 27676369
[TBL] [Abstract][Full Text] [Related]
38. Treatment capacity required for full-scale implementation of lung cancer screening in the United States.
Blom EF; Ten Haaf K; Arenberg DA; de Koning HJ
Cancer; 2019 Jun; 125(12):2039-2048. PubMed ID: 30811590
[TBL] [Abstract][Full Text] [Related]
39. A qualitative analysis of smokers' perceptions about lung cancer screening.
Gressard L; DeGroff AS; Richards TB; Melillo S; Kish-Doto J; Heminger CL; Rohan EA; Allen KG
BMC Public Health; 2017 Jun; 17(1):589. PubMed ID: 28637439
[TBL] [Abstract][Full Text] [Related]
40. Smoking, smoking cessation and smoking relapse patterns: a web-based survey of current and former smokers in the US.
Yeomans K; Payne KA; Marton JP; Merikle EP; Proskorovsky I; Zou KH; Li Q; Willke RJ
Int J Clin Pract; 2011 Oct; 65(10):1043-54. PubMed ID: 21923845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
